Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices - order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.
Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.
This activity is intended for Hem/Onc specialists, urologists, and emergency medicine specialists.
The goal of this activity is to provide clinicians with the latest data, concepts, and recommendations regarding the diagnosis, evidence-based treatment, counseling, and follow-up related to patients with advanced urothelial cancer.
Learning Objectives:
- Have greater competence related to ordering appropriate testing to determine patient eligibility for therapy in advanced urothelial carcinoma (UC).
- Have greater competence related to prescribing appropriate therapy in a patient with advanced UC based on patient and disease-specific factors.
- Have greater competence related to providing appropriate conseling and follow-up for a patient receiving treatment for advanced UC.
Approximate Time to Complete: 60 minutes
Credit Available: April 28, 2020 - April 28, 2021
Developed through a partnership between SITC and Medscape.
 |
|
Additional Resources for Clinicans from SITC:
"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma" (Published August 15, 2017)